Reasons for Being "Zero-Dose and Under-Vaccinated" among Children Aged 12-23 Months in the Democratic Republic of the Congo.

Autor: Ishoso DK; Immunization and Vaccines Development (IVD) Program, World Health Organization (WHO), Country Office, Kinshasa 01205, Democratic Republic of the Congo.; Kinshasa School of Public Health (KSPH), University of Kinshasa, Kinshasa 01302, Democratic Republic of the Congo., Mafuta E; Kinshasa School of Public Health (KSPH), University of Kinshasa, Kinshasa 01302, Democratic Republic of the Congo., Danovaro-Holliday MC; Immunization, Analytics and Insights (IAI), Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), 1211 Geneva, Switzerland., Ngandu C; National Institute of Public Health, Kinshasa 01209, Democratic Republic of the Congo., Menning L; Immunization, Analytics and Insights (IAI), Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), 1211 Geneva, Switzerland., Cikomola AM; Expanded Program of Immunization, Kinshasa 01208, Democratic Republic of the Congo., Lungayo CL; Expanded Program of Immunization, Kinshasa 01208, Democratic Republic of the Congo., Mukendi JC; Expanded Program of Immunization, Kinshasa 01208, Democratic Republic of the Congo., Mwamba D; National Institute of Public Health, Kinshasa 01209, Democratic Republic of the Congo., Mboussou FF; Communicable and Noncommunicable Diseases Cluster, World Health Organization Inter-Country Support Teams Central Africa, Libreville BP 820, Gabon., Manirakiza D; United Nations Children's Fund (UNICEF) Country Office, Kinshasa 01204, Democratic Republic of the Congo., Yapi MD; Immunization and Vaccines Development (IVD) Program, World Health Organization (WHO), Country Office, Kinshasa 01205, Democratic Republic of the Congo., Ngabo GF; Immunization and Vaccines Development (IVD) Program, World Health Organization (WHO), Country Office, Kinshasa 01205, Democratic Republic of the Congo., Riziki RB; Immunization and Vaccines Development (IVD) Program, World Health Organization (WHO), Country Office, Kinshasa 01205, Democratic Republic of the Congo.; Public Health Section, Higher Institute of Medical Techniques of Nyangezi, Sud-Kivu 11213, Democratic Republic of the Congo., Aluma ADL; Independent Researcher, Moroni 99397, Comoros., Tsobeng BN; Immunization and Vaccines Development (IVD) Program, World Health Organization (WHO), Country Office, Kinshasa 01205, Democratic Republic of the Congo., Mwanga C; Immunization and Vaccines Development (IVD) Program, World Health Organization (WHO), Country Office, Kinshasa 01205, Democratic Republic of the Congo., Otomba J; Immunization and Vaccines Development (IVD) Program, World Health Organization (WHO), Country Office, Kinshasa 01205, Democratic Republic of the Congo., Lulebo A; Kinshasa School of Public Health (KSPH), University of Kinshasa, Kinshasa 01302, Democratic Republic of the Congo., Lusamba P; Kinshasa School of Public Health (KSPH), University of Kinshasa, Kinshasa 01302, Democratic Republic of the Congo., Nimpa MM; Immunization and Vaccines Development (IVD) Program, World Health Organization (WHO), Country Office, Kinshasa 01205, Democratic Republic of the Congo.

Publikováno v: Vaccines [Vaccines (Basel)] 2023 Aug 16; Vol. 11 (8). Date of Electronic Publication: 2023 Aug 16.

Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021.

Autor: Alleman MM; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, USA. Electronic address: mea4@cdc.gov., Jorba J; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, USA., Riziki Y; Institut National de Recherche Biomédicale, Ministry of Public Health, Hygiene and Prevention, Democratic Republic of the Congo., Henderson E; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, USA., Mwehu A; Emergency Operations Center for Polio, Ministry of Public Health, Hygiene and Prevention, Democratic Republic of the Congo., Seakamela L; National Institute for Communicable Diseases, National Health Laboratory Services, South Africa., Howard W; National Institute for Communicable Diseases, National Health Laboratory Services, South Africa., Kadiobo Mbule A; Polio, Office of the Regional Director, World Health Organization, Democratic Republic of the Congo Country Office, Democratic Republic of the Congo., Nsamba RN; Polio, Office of the Regional Director, World Health Organization, Democratic Republic of the Congo Country Office, Democratic Republic of the Congo., Djawe K; Polio, Office of the Regional Director, World Health Organization, Democratic Republic of the Congo Country Office, Democratic Republic of the Congo., Yapi MD; Polio, Office of the Regional Director, World Health Organization, Democratic Republic of the Congo Country Office, Democratic Republic of the Congo., Mengouo MN; Polio, Office of the Regional Director, World Health Organization, Democratic Republic of the Congo Country Office, Democratic Republic of the Congo., Gumede N; Polio, Office of the Regional Director, World Health Organization, Regional Office for Africa, Republic of the Congo., Ndoutabe M; Polio, Office of the Regional Director, World Health Organization, Regional Office for Africa, Republic of the Congo., Kfutwah AKW; Polio, Office of the Regional Director, World Health Organization, Regional Office for Africa, Republic of the Congo., Senouci K; Bill and Melinda Gates Foundation, Washington, USA., Burns CC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, USA.

Publikováno v: Vaccine [Vaccine] 2023 Apr 06; Vol. 41 Suppl 1, pp. A35-A47. Date of Electronic Publication: 2023 Mar 11.

Experiences and Lessons From Polio Eradication Applied to Immunization in 10 Focus Countries of the Polio Endgame Strategic Plan.

Autor: van den Ent MMVX; Program Division, UNICEF Headquarters, New York, New York., Mallya A; Polio Team, Bill and Melinda Gates Foundation, Seattle, Washington., Sandhu H; Global Immunization Division, CDC, Atlanta, Georgia., Anya BP; WHO Africa Regional Office, Brazzaville, Congo., Yusuf N; UNICEF East and Southern Africa Regional Office, Nairobi, Kenya., Ntakibirora M; UNICEF West and Central Africa Regional Office, Dakar, Senegal., Hasman A; UNICEF Regional Office for South Asia, Kathmandu, Nepal., Fahmy K; WHO Eastern Mediterranean Regional Office, Cairo, Egypt., Agbor J; UNICEF Afghanistan, Afghanistan., Corkum M; UNICEF Nigeria Country Office, Abuja, Nigeria., Sumaili K; UNICEF Nigeria Country Office, Abuja, Nigeria., Siddique AR; UNICEF Nigeria Country Office, Abuja, Nigeria., Bammeke J; UNICEF Nigeria Country Office, Abuja, Nigeria., Braka F; WHO Nigeria Country Office, Abuja, Nigeria., Andriamihantanirina R; UNICEF DRC Country Office, Kinshasa, Democratic Republic of Congo., Ziao AC; UNICEF DRC Country Office, Kinshasa, Democratic Republic of Congo., Djumo C; UNICEF Chad Country Office, N'Djamena, Chad., Yapi MD; WHO DRC Country Office, Kinshasa, Democratic Republic of Congo., Sosler S; Gavi, the Vaccine Alliance, Geneva, Switzerland., Eggers R; WHO Kenya Country Office, Nairobi, Kenya.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2017 Jul 01; Vol. 216 (suppl_1), pp. S250-S259.